Aarhus University Seal

Publications

Sort by: Date | Author | Title

Skriver, M. V., Nørgaard, M., Poulsen, AH., Friis, S., Harving, H., Fryzek, J., McLaughlin, JK., Blot, WJ., Olsen, JH. & Sørensen, H. T. (2005). Use of nonaspirin NSAIDs and risk of lung cancer. International Journal of Cancer, 117, 873-6.
Levintow, S. N., Orroth, K. K., Breskin, A., Park, A. S., Flores-Arredondo, J. H., Dluzniewski, P., Navar, A. M., Sørensen, H. T. & Brookhart, M. A. (2022). Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. Pharmacoepidemiology and Drug Safety, 31(4), 383-392. https://doi.org/10.1002/pds.5396
Polesie, S., Gillstedt, M., Schmidt, S. A. J., Egeberg, A., Pottegård, A. & Kristensen, K. (2023). Use of methotrexate and risk of skin cancer: a nationwide case-control study. British Journal of Cancer, 128(7), 1311-1319. https://doi.org/10.1038/s41416-023-02172-7
Skriver, C., Dehlendorff, C., Borre, M., Brasso, K., Larsen, S. B., Dalton, S. O., Nørgaard, M., Pottegård, A., Hallas, J., Sørensen, H. T. & Friis, S. (2019). Use of Low-Dose Aspirin and Mortality After Prostate Cancer Diagnosis: A Nationwide Cohort Study. Annals of Internal Medicine, 170(7), 443-452. https://doi.org/10.7326/M17-3085
Riahi, S., Fonager, K., Hvilsted-Rasmussen, L., Bendsen, J., Johnsen, S. P. & Sørensen, H. T. (2001). Use of lipid-lowering drugs during 1991-98 in Northern Jutland; Denmark. British Journal of Clinical Pharmacology, 52, 307-311.
Pottegård, A., Pedersen, S. A., Schmidt, S. A. J., Lee, C.-N., Hsu, C.-K., Liao, T.-C., Shao, S.-C. & Lai, E. C.-C. (2019). Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. British Journal of Cancer, 121(11), 973-978. https://doi.org/10.1038/s41416-019-0613-4
Nørgaard, M., Poulsen, AH., Gregersen, H. E., Friis, S., Ewertz, M. K., Johnsen, HE. & Sørensen, H. T. (2005). Use of hormone replacement therapy and risk of non-Hodgkin lymphoma. Poster session presented at 21st International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Nashville, United States.
Lietzen, L. W., Ahern, T., Jensen, A. B., Christiansen, P. M., Sørensen, H. T., Lash, T. & Cronin Fenton, D. (2013). Use of Glucocorticoids and Risk of Breast Cancer Recurrence. Abstract from 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Montreal, Canada.
Czeizel, A. E., Rockenbauer, M., Sørensen, H. T. & Olsen, J. (2001). Use of cephalosporins during pregnancy and in the presence of congenital abnormalities. American Journal of Obstetrics and Gynecology, 184, 1289-1296.
Olesen, T. B., Andersen, I. T., Ording, A. G., Ehrenstein, V., Seesaghur, A., Helleberg, C., Silkjær, T., Hernandez, R. K., Niepel, D. & Abildgaard, N. (2021). Use of bisphosphonates in multiple myeloma patients in Denmark, 2005–2015. Supportive Care in Cancer, 29(8), 4501-4511. https://doi.org/10.1007/s00520-020-05934-8
Kristensen, P. K., Ehrenstein, V., Shetty, N. & Pedersen, A. B. (2018). Use of bisphosphonates before and after hip fracture surgery: A Danish population-based prevalence study, 2005-2015. Poster session presented at 34rd international Conference for Pharmacoepidemiology and therapeutic risk Management (ICPE), Prag, Czech Republic.
Kristensen, P. K., Ehrenstein, V., Shetty, N. & Pedersen, A. B. (2018). Use of bisphosphonates before and after hip fracture surgery: A Danish population-based prevalence study, 2005-2015. Abstract from 34rd international Conference for Pharmacoepidemiology and therapeutic risk Management (ICPE), Prag, Czech Republic.
Kristensen, P. K., Ehrenstein, V., Shetty, N. & Pedersen, A. B. (2018). Use of bisphosphonates before and after hip fracture. Abstract from Danish Orthopaedic Society Congress 2018, København, Denmark.
Gottschau, M., Bens, A., Friis, S., Cronin-Fenton, D., Aalborg, G. L., Jensen, M.-B., Ejlertsen, B., Kroman, N. & Mellemkjaer, L. (2022). Use of beta-blockers and risk of contralateral breast cancer. International Journal of Cancer, 150(10), 1619-1626. https://doi.org/10.1002/ijc.33923
Trifirò, G., de Ridder, M., Sultana, J., Oteri, A., Rijnbeek, P., Pecchioli, S., Mazzaglia, G., Bezemer, I., Garbe, E., Schink, T., Poluzzi, E., Frøslev, T., Molokhia, M., Diemberger, I. & Sturkenboom, M. C. J. M. (2017). Use of azithromycin and risk of ventricular arrhythmia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 189(15), E560-E568. https://doi.org/10.1503/cmaj.160355
Wogelius, P., Viuff, J. & Haubek, D. (2020). Use of Asthma Drugs and Prevalence of Molar Incisor Hypomineralization. International Journal of Paediatric Dentistry, 30(6), 734-740. https://doi.org/10.1111/ipd.12655
Kaguelidou, F., Holstiege, J., Schink, T., Bezemer, I., Poluzzi, E., Mazzaglia, G., Pedersen, L., Sturkenboom, M. & Trifirò, G. (2020). 'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study'. Epidemiology and Psychiatric Sciences, 29, Article e117. https://doi.org/10.1017/S2045796020000293
Poluzzi, E., Diemberger, I., De Ridder, M., Koci, A., Clo, M., Oteri, A., Pecchioli, S., Bezemer, I., Schink, T., Ulrichsen, S. P., Boriani, G., Sturkenboom, M. C. J., De Ponti, F. & Trifiro, G. (2017). Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. European Journal of Clinical Pharmacology, 73(11), 1499-1510. https://doi.org/10.1007/s00228-017-2317-0
Kristensen, K. B., Pedersen, S. A., Schmidt, S. A. J. & Pottegård, A. (2020). Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study. Journal of the American Academy of Dermatology, 82(2), 326-335. https://doi.org/10.1016/j.jaad.2019.05.055